Statements (50)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
opioid
|
| gptkbp:chemicalFormula |
C18H21NO3
|
| gptkbp:hasFilm |
nausea
drowsiness constipation |
| gptkbp:hasProductLine |
pharmaceutical companies
|
| gptkbp:hasResearchInterest |
pain management
cough treatment |
| https://www.w3.org/2000/01/rdf-schema#label |
codeine
|
| gptkbp:isAssociatedWith |
tolerance
dependence addiction risk |
| gptkbp:isAttendedBy |
tablet
injection syrup |
| gptkbp:isAvailableIn |
liquid form
generic drug solid form |
| gptkbp:isFacilitatedBy |
Schedule II
Schedule III |
| gptkbp:isInvolvedIn |
drug interactions
overdose cases |
| gptkbp:isLedBy |
prescription required
|
| gptkbp:isPartOf |
WHO Model List of Essential Medicines
combination medications narcotic analgesics cough treatment protocols pain management protocols antitussives |
| gptkbp:isRecognizedFor |
pregnant women
children under 12 people with respiratory issues |
| gptkbp:isRelatedTo |
heroin
morphine oxycodone hydrocodone |
| gptkbp:isSubjectTo |
regulatory oversight
drug testing prescription monitoring |
| gptkbp:isUsedFor |
chronic pain
pain relief guaifenesin aspirin acetaminophen severe cough acute_pain cough_suppression |
| gptkbp:isUsedIn |
cough treatment for animals
pain relief for animals |
| gptkbp:isValuedFor |
opium
|